Palisade Bio

Palisade Bio P/B

The P/B (Price-to-Book Ratio) of Palisade Bio (PALI) as of Oct 16, 2026 is 1.99. In the previous year, P/B (Price-to-Book Ratio) was 34.41 — a change of -94.21% (lower).

P/B

1.99

YoY

-94.21%

Last updated:

P/B (Price-to-Book Ratio) of Palisade Bio is 2025 1.99 . P/B (Price-to-Book Ratio) of Palisade Bio was 2024 34.41 . It decreases by -94.21% lower compared to the previous year.

The Palisade Bio P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2018
42.61 USD
Jan 1, 2019
50.29 USD
Jan 1, 2020
-36.31 USD
Jan 1, 2021
35.00 USD
Jan 1, 2022
20.66 USD
Jan 1, 2023
22.79 USD
Jan 1, 2024
34.41 USD
Jan 1, 2025
1.99 USD
The Palisade Bio P/B history
YEARP/BYoY
1.99-94.21%
34.41+51.00%
22.79+10.31%
20.66-40.98%
35.00-196.39%
-36.31-172.21%
50.29+18.02%
42.61+40.76%
30.27+33.07%
22.75-56.16%
51.89+256.72%
14.55—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Palisade Bio Stock analysis

What does Palisade Bio do? Palisade Bio Inc is a biopharmaceutical company based in Carlsbad, California, focused on developing oral therapies for gastrointestinal complications following surgery. The company employs 14 people and went public on December 20, 2006. Its lead candidate, LB1148, is an oral liquid formulation containing tranexamic acid, polyethylene glycol, carbohydrates, and electrolytes, designed to prevent digestive enzyme leakage into the peritoneal cavity during high-risk surgeries. The company's approach targets intestinal epithelial barrier damage that can cause inflammation and tissue damage. Palisade Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Palisade Bio stock

P/B (Price-to-Book Ratio) of Palisade Bio is 1.99 in 2025.

P/B (Price-to-Book Ratio) of Palisade Bio changed from 34.41 to 1.99, representing a -94.21% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Palisade Bio since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Palisade Bio with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Palisade Bio

All Key Metrics — Palisade Bio